![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity
Neha Dagar, Tahib Habshi, Vishwadeep Shelke, et al.
Free Radical Research (2024) Vol. 58, Iss. 2, pp. 69-87
Closed Access | Times Cited: 5
Neha Dagar, Tahib Habshi, Vishwadeep Shelke, et al.
Free Radical Research (2024) Vol. 58, Iss. 2, pp. 69-87
Closed Access | Times Cited: 5
Showing 5 citing articles:
Esculetin improves inflammation of the kidney via gene expression against doxorubicin-induced nephrotoxicity in rats: In vivo and in silico studies
Medine Sibel Karağaç, Esra Nur Yeşilkent, Duygu Kizir, et al.
Food Bioscience (2024), pp. 105159-105159
Closed Access | Times Cited: 5
Medine Sibel Karağaç, Esra Nur Yeşilkent, Duygu Kizir, et al.
Food Bioscience (2024), pp. 105159-105159
Closed Access | Times Cited: 5
The protective effects of esculetin against Doxorubicin‐Induced hepatotoxicity in rats: Insights into the modulation of Caspase, FOXOs, and heat shock protein pathways
Duygu Kizir, Esra Nur Yeşilkent, Neslihan Öztürk, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 10
Closed Access | Times Cited: 3
Duygu Kizir, Esra Nur Yeşilkent, Neslihan Öztürk, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 10
Closed Access | Times Cited: 3
Advances in CRISPR-Cas systems for kidney diseases
Bhupendra Puri, Yogesh A. Kulkarni, Anil Bhanudas Gaikwad
Progress in molecular biology and translational science (2024), pp. 149-162
Closed Access | Times Cited: 1
Bhupendra Puri, Yogesh A. Kulkarni, Anil Bhanudas Gaikwad
Progress in molecular biology and translational science (2024), pp. 149-162
Closed Access | Times Cited: 1
Novel dysregulated long non‐coding RNAs in the acute kidney injury‐to‐chronic kidney diseases transition unraveled by transcriptomic analysis
Bhupendra Puri, Syamantak Majumder, Anil Bhanudas Gaikwad
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 1
Bhupendra Puri, Syamantak Majumder, Anil Bhanudas Gaikwad
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 1
Chinese botanical drugs targeting mitophagy to alleviate diabetic kidney disease, a comprehensive review
Leilei Ma, Jing Li, Xiaotian Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Leilei Ma, Jing Li, Xiaotian Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access